Skip to Main Content

News Roundup

Yale Targets COVID-19 with Innovative Computational Design Methods

Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics — exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication approved for use against the virus.

Source: YaleNews
Read more